Nintedanib benefits patients with autoimmune disease-related lung diseases

A new clinical published in Arthritis & Rheumatology reveals that nintedanib, a medication that helps prevent changes to lung tissue, may help patients with fibrosing autoimmune disease-related interstitial lung diseases (ILDs), which are a common manifestation of systemic autoimmune diseases such as rheumatoid arthritis.

source https://medicalxpress.com/news/2022-02-nintedanib-benefits-patients-autoimmune-disease-related.html